Microbio
Australian biotechnology company developing molecular diagnostics for rapid identification of bloodstream infection pathogens. The organisation combines bioinformatics, genomics and molecular microbiology to produce qPCR-based assays that detect and quantify pathogens directly from whole blood and supports commercialisation, manufacturing and distribution of those assays.
Industries
Nr. of Employees
small (1-50)
Products
Bloodstream infection molecular diagnostic assay (qPCR-based)
A qPCR-based diagnostic assay for direct detection and identification of a panel of sepsis-associated bacterial and yeast pathogens from whole blood with a reported laboratory turnaround of approximately three hours and validated low-volume sampling.
Assay client software for data analysis and workflow management
Client software supporting assay result interpretation, data handling and integration with laboratory workflows.
Bloodstream infection molecular diagnostic assay (qPCR-based)
A qPCR-based diagnostic assay for direct detection and identification of a panel of sepsis-associated bacterial and yeast pathogens from whole blood with a reported laboratory turnaround of approximately three hours and validated low-volume sampling.
Assay client software for data analysis and workflow management
Client software supporting assay result interpretation, data handling and integration with laboratory workflows.
Services
On-site and remote scientific/technical consultation, troubleshooting, hands-on training in customer laboratories, and support for distributor product specialists.
Management of regional distribution agreements and distributor onboarding/support for assay deployment.
On-site and remote scientific/technical consultation, troubleshooting, hands-on training in customer laboratories, and support for distributor product specialists.
Management of regional distribution agreements and distributor onboarding/support for assay deployment.
Expertise Areas
- Molecular diagnostics
- qPCR assay development
- Clinical diagnostics for bloodstream infections (sepsis)
- Bioinformatics for pathogen identification
Key Technologies
- Quantitative PCR (qPCR)
- High-resolution melt-curve analysis
- SNP-targeted molecular assays
- Direct whole-blood molecular detection
News & Updates
Announcement of a distribution agreement to enter the Danish market.
Announcement of appointment of a new Chief Commercial Officer.
Blog post summarising global sepsis incidence, mortality and the role of diagnostics.
Resource describing analytical performance evaluation and a published study assessing a whole-blood qPCR assay.
Awarded ISO 13485:2016 certification for the quality management system.
IVD clearance under the referenced IVD directive for the bloodstream infection assay; reported clearance for sale in Europe and the UK and market access in India.
Announcement of a distribution agreement to enter the Danish market.
Announcement of appointment of a new Chief Commercial Officer.
Blog post summarising global sepsis incidence, mortality and the role of diagnostics.
Resource describing analytical performance evaluation and a published study assessing a whole-blood qPCR assay.
Awarded ISO 13485:2016 certification for the quality management system.
IVD clearance under the referenced IVD directive for the bloodstream infection assay; reported clearance for sale in Europe and the UK and market access in India.